首页> 外文期刊>American Journal of Pathology >MYCN Promotes the Expansion of Phox2B-Positive Neuronal Progenitors to Drive Neuroblastoma Development
【24h】

MYCN Promotes the Expansion of Phox2B-Positive Neuronal Progenitors to Drive Neuroblastoma Development

机译:MYCN促进Phox2B阳性神经元祖细胞的扩展,以驱动神经母细胞瘤的发展。

获取原文
获取原文并翻译 | 示例
           

摘要

Amplification of the oncogene MYCN is a tumorigenic event in the development of a subset of neuroblastomas that commonly consist of undifferentiated or poorly differentiated neuroblasts with unfavorable clinical outcome. The cellular origin of these neuroblasts is unknown. Additionally, the cellular functions and target cells of MYCN in neuroblastoma development remain undefined. Here we examine the cell types that drive neuroblastoma development in TH-MYCN transgenic mice, an animal model of the human disease. Neuroblastoma development in these mice begins with hyperplastic lesions in early postnatal sympathetic ganglia. We show that both hyperplasia and primary tumors are composed predominantly of highly proliferative Phox2B+ neuronal progenitors. MYCN induces the expansion of these progenitors by both promoting their proliferation and preventing their differentiation. We further identify a minor population of undifferentiated nestin+ cells in both hyperplastic lesions and primary tumors that may serve as precursors of Phox2B+ neuronal progenitors. These findings establish the identity of neuroblasts that characterize the tumor phenotype and suggest a cellular pathway by which MYCN can promote neuroblastoma development.
机译:癌基因MYCN的扩增是 一部分神经母细胞瘤的发展中的致癌事件,通常由 组成未分化或分化程度差的神经母细胞 ,临床上不利结果。这些 神经母细胞的细胞起源是未知的。此外,在神经母细胞瘤发展过程中,MYCN的细胞功能 和靶细胞仍然 。在这里,我们研究了驱动TH-MYCN转基因小鼠( 人类疾病的动物模型)中神经母细胞瘤 发育的细胞类型。这些小鼠的神经母细胞瘤发展始于出生后早期交感神经节的增生性病变。 我们证明增生和原发性肿瘤均由 组成,主要是高度增生的Phox2B + 神经元祖细胞。 MYCN通过促进 增殖并阻止其分化来诱导这些祖细胞的扩增。我们 进一步在增生性病变和原发肿瘤中鉴定出少数未分化的巢蛋白 + 细胞,这些细胞可能 Phox2B + 神经元祖细胞的前体。这些发现 建立了表征 肿瘤表型的成神经细胞的身份,并提出了MYCN 可以促进成神经细胞瘤发展的细胞途径。 / sup>

著录项

  • 来源
    《American Journal of Pathology》 |2009年第2期|856-866|共11页
  • 作者单位

    From the Department of Biochemistry and Cancer Biology,University of Toledo College of Medicine, Toledo, Ohio;

    From the Department of Biochemistry and Cancer Biology,University of Toledo College of Medicine, Toledo, Ohio;

    From the Department of Biochemistry and Cancer Biology,University of Toledo College of Medicine, Toledo, Ohio;

    From the Department of Biochemistry and Cancer Biology,University of Toledo College of Medicine, Toledo, Ohio;

    the Department of Pathology and Cancer Center,Medical College of Georgia, Augusta, Georgia;

    and the Department of Neurology,Union Hospital, Huazhong University of Science and Technology, Wuhan, China;

    From the Department of Biochemistry and Cancer Biology,University of Toledo College of Medicine, Toledo, Ohio;

    the Department of Pathology and Cancer Center,Medical College of Georgia, Augusta, Georgia;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号